Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex

被引:455
作者
Fujihara, M
Muroi, M
Tanamoto, K
Suzuki, T
Azuma, H
Ikeda, H
机构
[1] Hokkaido Red Cross Blood Ctr, Japanese Red Cross, Nishi Ku, Sapporo, Hokkaido 0630002, Japan
[2] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA
[3] Natl Inst Hlth Sci, Div Microbiol, Setagaya Ku, Tokyo 1588501, Japan
关键词
LPS; macrophages; CD14; TLR4; MD-2; endotoxin tolerance;
D O I
10.1016/j.pharmthera.2003.08.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Bacterial lipopolysaccharide (LPS), the major structural component of the outer wall of Gram-negative bacteria, is a potent activator of macrophages. Activated macrophages produce a variety of inflammatory cytokines. Excessive production of cytokines in response to LPS is regarded as the cause of septic shock. On the other hand, macrophages exposed to suboptimal doses of LPS are rendered tolerant to subsequent exposure to LPS and manifest a profoundly altered response to LPS. Increasing evidence suggests that monocytic cells from patients with sepsis and septic shock survivors have characteristics of LPS tolerance. Thus, an understanding of the molecular mechanisms underlying activation and deactivation of macrophages in response to LPS is important for the development of therapeutics for septic shock and the treatment of septic shock survivors. Over the past several years, significant progress has been made in identifying and characterizing several key molecules and signal pathways involved in the regulation of macrophage functions by LPS. In this paper, we summarize the current findings of the functions of the LPS receptor complex, which is composed of CD14, Toll-like receptor 4 (TLR4), and myeloid differentiation protein-2 (MD-2), and the signal pathways of this LPS receptor complex with regard to both activation and deactivation of macrophages by LPS. In addition, recent therapeutic approaches for septic shock targeting the LPS receptor complex are described. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:171 / 194
页数:24
相关论文
共 232 条
  • [61] THE TOLL GENE OF DROSOPHILA, REQUIRED FOR DORSAL-VENTRAL EMBRYONIC POLARITY, APPEARS TO ENCODE A TRANSMEMBRANE PROTEIN
    HASHIMOTO, C
    HUDSON, KL
    ANDERSON, KV
    [J]. CELL, 1988, 52 (02) : 269 - 279
  • [62] The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
    Hayashi, F
    Smith, KD
    Ozinsky, A
    Hawn, TR
    Yi, EC
    Goodlett, DR
    Eng, JK
    Akira, S
    Underhill, DM
    Aderem, A
    [J]. NATURE, 2001, 410 (6832) : 1099 - 1103
  • [63] Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice
    Haziot, A
    Ferrero, E
    Kontgen, F
    Hijiya, N
    Yamamoto, S
    Silver, J
    Stewart, CL
    Goyert, SM
    [J]. IMMUNITY, 1996, 4 (04) : 407 - 414
  • [64] Heine H, 1999, J IMMUNOL, V162, P6971
  • [65] Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway
    Hemmi, H
    Kaisho, T
    Takeuchi, O
    Sato, S
    Sanjo, H
    Hoshino, K
    Horiuchi, T
    Tomizawa, H
    Takeda, K
    Akira, S
    [J]. NATURE IMMUNOLOGY, 2002, 3 (02) : 196 - 200
  • [66] A Toll-like receptor recognizes bacterial DNA
    Hemmi, H
    Takeuchi, O
    Kawai, T
    Kaisho, T
    Sato, S
    Sanjo, H
    Matsumoto, M
    Hoshino, K
    Wagner, H
    Takeda, K
    Akira, S
    [J]. NATURE, 2000, 408 (6813) : 740 - 745
  • [67] HerreraVelit P, 1996, J IMMUNOL, V156, P1157
  • [68] Cutting edge: Repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2
    Hirschfeld, M
    Ma, Y
    Weis, JH
    Vogel, SN
    Weis, JJ
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (02) : 618 - 622
  • [69] Hirschfeld M, 1999, J IMMUNOL, V163, P2382
  • [70] Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells
    Hornef, MW
    Frisan, T
    Vandewalle, A
    Normark, S
    Richter-Dahlfors, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) : 559 - 570